Allogeneic Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye Disease Patients
Journal of Clinical Medicine · 25.10.2023 · 12 (21) · 6750
DOI: 10.3390/jcm12216750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.10.2023. Verfasst von Joy Wong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore 168751, Singapore. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council.
Abstract (Originalsprache)
Background
Dry eye disease is a significant disease in Singapore. While there have been studies using allogenic cord serum for the treatment of dry eye disease, treatment of dry eyes with allogenic umbilical cord plasma drops has yet to be started in Singapore.
Purpose
To evaluate the effectiveness of umbilical cord plasma eyedrops for the treatment of recalcitrant dry eyes in a local Singaporean context.
Methods
This is an observational, longitudinal, interventional study for dry eye patients who did not show clear improvement after standard therapy. Patients were recruited from 2020 to 2023 from the dry eye clinic of the Singapore National Eye Center. Umbilical cord plasma was delivered frozen to patients and stored in home freezers. All participants underwent a standardized clinical evaluation for dry eye, and data were collected.
Results
There were 40 participants (7 males and 33 females). The duration of follow-up was 5.52 ± 1.57 months. Kerato-epitheliopathy staining score, TBUT (tear breakup time), and SPEED (Standard Patient Evaluation of Eye Dryness Questionnaire) scores significantly improved after treatment. No statistically significant improvement was found in terms of visual acuity, according to Schirmer’s score.
Conclusion
Cord plasma eye drops significantly improved kerato-epitheliopathy staining scores in recalcitrant dry eye patients. Allogeneic plasma is a promising form of treatment for recalcitrant dry eye.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore 168751, Singapore.
- Singapore Cord Blood Bank, 100 Bukit Timah Road, KK Women's & Children's Hospital Women's Tower, Women's Specialist Clinics, Level 1, Singapore 229899, Singapore.
- Department of Haematology, Singapore General Hospital, 31 Third Hospital Avenue, Singapore 168753, Singapore.
- Singapore Eye Research Institute, 20 College Road Discovery Tower Level 6, The Academia, Singapore 169856, Singapore.
- Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.
- Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore.
ORCID-Profile: Joy Wong, Louis Tong
Förderung
- National Medical Research Council
Zitieren
APA
Wong, J., Govindasamy, G., Prasath, A., Hwang, W., Ho, A., Yeo, S., & Tong, L. (2023). Allogeneic Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye Disease Patients. Journal of Clinical Medicine, 12(21), 6750. https://doi.org/10.3390/jcm12216750
Vancouver
Wong J, Govindasamy G, Prasath A, Hwang W, Ho A, Yeo S, et al. Allogeneic Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye Disease Patients. Journal of Clinical Medicine. 2023;12(21):6750. doi:10.3390/jcm12216750
BibTeX
@article{Wong2023,
author = {Wong, Joy and Govindasamy, Gayathri and Prasath, Arun and Hwang, William and Ho, Aloysius and Yeo, Sharon and Tong, Louis},
title = {Allogeneic Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye Disease Patients},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {21},
pages = {6750},
doi = {10.3390/jcm12216750}
}
EUVIMED